{
    "2021-09-04": [
        [
            {
                "time": "2021-10-15",
                "original_text": "U.S. administers 374.5 mln doses of COVID-19 vaccines -CDC",
                "features": {
                    "keywords": [
                        "U.S.",
                        "COVID-19 vaccines",
                        "CDC"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "This Is the COVID Vaccine Stock You Want to Own",
                "features": {
                    "keywords": [
                        "COVID Vaccine Stock",
                        "Own"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "Vaccine mandates: Employees paying to be unvaccinated is 'very much like smoking surcharges,' expert explains",
                "features": {
                    "keywords": [
                        "Vaccine mandates",
                        "Employees",
                        "unvaccinated",
                        "smoking surcharges"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "employment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "Even with Vaccine Success, Pfizer (NYSE:PFE) Returns are Lagging the Broad Market",
                "features": {
                    "keywords": [
                        "Vaccine Success",
                        "Pfizer",
                        "Returns",
                        "Broad Market"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "Are COVID Vaccine Mandates Justified Based on the Data?",
                "features": {
                    "keywords": [
                        "COVID Vaccine Mandates",
                        "Data"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public policy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "At Less Than $50, Could Pfizer Reach $100 Before 2025?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "$50",
                        "$100",
                        "2025"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "Why Investors Should Love Pfizer's Acquisition of Trillium",
                "features": {
                    "keywords": [
                        "Investors",
                        "Pfizer",
                        "Acquisition",
                        "Trillium"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}